Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
DARIFENACIN
(2004)
Small molecule
Unknown
Unknown
Approved
Polyuria; Urinary Incontinence
DARIFENACIN
×
Maximum Phase:
4
First Approval:
2004
UNII:
APG9819VLM
Molecule Type:
Small molecule
Molecular Formula:
C28H30N2O2
Molecular Weight:
426.56
AlogP:
3.96
PSA:
55.56
HBD:
1.0
HBA:
#RotB:
7.0
Source:
BISACODYL
(2004)
Small molecule
Unknown
Unknown
Approved
Constipation
BISACODYL
×
Maximum Phase:
4
First Approval:
2004
UNII:
10X0709Y6I
Molecule Type:
Small molecule
Molecular Formula:
C22H19NO4
Molecular Weight:
361.4
AlogP:
4.11
PSA:
65.49
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PEMETREXED
(2004)
Small molecule
Unknown
INJECTION; INTRAVENOUS; IV (INFUSION)
Approved
Mesothelioma; Neoplasms
PEMETREXED
×
Maximum Phase:
4
First Approval:
2004
UNII:
04Q9AIZ7NO
Molecule Type:
Small molecule
Molecular Formula:
C20H21N5O6
Molecular Weight:
427.42
AlogP:
0.67
PSA:
191.26
HBD:
6.0
HBA:
#RotB:
9.0
Source:
METHYL AMINOLEVULINATE HYDROCHLORIDE
(2004)
Small molecule
DNA inhibitor
TOPICAL
Approved
Glioma
METHYL AMINOLEVULINATE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2004
UNII:
7S73606O1A
Molecule Type:
Small molecule
Molecular Formula:
C6H12ClNO3
Molecular Weight:
181.62
AlogP:
-0.53
PSA:
69.39
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ACAMPROSATE CALCIUM
(2004)
Small molecule
GABA-A receptor; anion channel positive modulator
ORAL
Approved
Alcoholism
ACAMPROSATE CALCIUM
×
Maximum Phase:
4
First Approval:
2004
UNII:
59375N1D0U
Molecule Type:
Small molecule
Molecular Formula:
C10H20CaN2O8S2
Molecular Weight:
400.49
AlogP:
-0.6
PSA:
83.47
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PENTETATE ZINC TRISODIUM
(2004)
Small molecule
Radioactive metals chelating agent
INHALATION; INTRAVENOUS
Approved
Unknown
PENTETATE ZINC TRISODIUM
×
Maximum Phase:
4
First Approval:
2004
UNII:
NXU65IC8PG
Molecule Type:
Small molecule
Molecular Formula:
C14H18N3Na3O10Zn
Molecular Weight:
522.67
AlogP:
-2.68
PSA:
196.22
HBD:
5.0
HBA:
#RotB:
16.0
Source:
ERLOTINIB HYDROCHLORIDE
(2004)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung
ERLOTINIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2004
UNII:
DA87705X9K
Molecule Type:
Small molecule
Molecular Formula:
C22H24ClN3O4
Molecular Weight:
429.9
AlogP:
3.41
PSA:
74.73
HBD:
1.0
HBA:
#RotB:
10.0
Source:
APOMORPHINE
(2004)
Small molecule
Unknown
Unknown
Approved
Erectile Dysfunction; Parkinson Disease
APOMORPHINE
×
Maximum Phase:
4
First Approval:
2004
UNII:
N21FAR7B4S
Molecule Type:
Small molecule
Molecular Formula:
C17H17NO2
Molecular Weight:
267.33
AlogP:
2.85
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
0.0
Source:
SOLIFENACIN
(2004)
Small molecule
Unknown
Unknown
Approved
Polyuria; Urinary Incontinence
SOLIFENACIN
×
Maximum Phase:
4
First Approval:
2004
UNII:
A8910SQJ1U
Molecule Type:
Small molecule
Molecular Formula:
C23H26N2O2
Molecular Weight:
362.47
AlogP:
3.86
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
2.0
Source:
MYCOPHENOLIC ACID
(2004)
Small molecule
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
ORAL
Approved
Immune System Diseases
MYCOPHENOLIC ACID
×
Maximum Phase:
4
First Approval:
2004
UNII:
HU9DX48N0T
Molecule Type:
Small molecule
Molecular Formula:
C17H20O6
Molecular Weight:
320.34
AlogP:
2.73
PSA:
93.06
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TROSPIUM CHLORIDE
(2004)
Small molecule
Muscarinic acetylcholine receptor M2 antagonist
ORAL
Approved
Urinary Bladder, Overactive; Urinary Incontinence, Urge
TROSPIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
2004
UNII:
1E6682427E
Molecule Type:
Small molecule
Molecular Formula:
C25H30ClNO3
Molecular Weight:
427.97
AlogP:
3.77
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DULOXETINE
(2004)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
DULOXETINE
×
Maximum Phase:
4
First Approval:
2004
UNII:
O5TNM5N07U
Molecule Type:
Small molecule
Molecular Formula:
C18H19NOS
Molecular Weight:
297.42
AlogP:
4.63
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TELITHROMYCIN
(2004)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Bacterial Infections; Infections; Pneumonia
TELITHROMYCIN
×
Maximum Phase:
4
First Approval:
2004
UNII:
KI8H7H19WL
Molecule Type:
Small molecule
Molecular Formula:
C43H65N5O10
Molecular Weight:
812.02
AlogP:
4.93
PSA:
171.85
HBD:
1.0
HBA:
#RotB:
11.0
Source:
CINACALCET
(2004)
Small molecule
Unknown
Unknown
Approved
Parathyroid Diseases
CINACALCET
×
Maximum Phase:
4
First Approval:
2004
UNII:
UAZ6V7728S
Molecule Type:
Small molecule
Molecular Formula:
C22H22F3N
Molecular Weight:
357.42
AlogP:
6.14
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
6.0
Source:
GLUTAMINE
(2004)
Small molecule
Unknown
Unknown
Approved
Anemia, Sickle Cell; Short Bowel Syndrome
GLUTAMINE
×
Maximum Phase:
4
First Approval:
2004
UNII:
0RH81L854J
Molecule Type:
Small molecule
Molecular Formula:
C5H10N2O3
Molecular Weight:
146.15
AlogP:
-1.34
PSA:
106.41
HBD:
3.0
HBA:
#RotB:
4.0
Source:
OMEGA-3-ACID ETHYL ESTERS
(2004)
Small molecule
Unknown
ORAL
Approved
Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypothyroidism
OMEGA-3-ACID ETHYL ESTERS
×
Maximum Phase:
4
First Approval:
2004
UNII:
D87YGH4Z0Q
Molecule Type:
Small molecule
Molecular Formula:
C46H70O4
Molecular Weight:
687.06
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LANTHANUM CARBONATE
(2004)
Small molecule
Phosphate sequestering agent
Unknown
Approved
Unknown
LANTHANUM CARBONATE
×
Maximum Phase:
4
First Approval:
2004
UNII:
490D9F069T
Molecule Type:
Small molecule
Molecular Formula:
C3La2O9
Molecular Weight:
457.84
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GADOBENATE DIMEGLUMINE
(2004)
Small molecule
Diagnostic agent
INTRAVENOUS
Approved
Unknown
GADOBENATE DIMEGLUMINE
×
Maximum Phase:
4
First Approval:
2004
UNII:
3Q6PPC19PO
Molecule Type:
Small molecule
Molecular Formula:
C29H45GdN4O16
Molecular Weight:
862.94
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ACAMPROSATE
(2004)
Small molecule
Unknown
Unknown
Approved
Alcoholism
ACAMPROSATE
×
Maximum Phase:
4
First Approval:
2004
UNII:
N4K14YGM3J
Molecule Type:
Small molecule
Molecular Formula:
C5H11NO4S
Molecular Weight:
181.21
AlogP:
-0.6
PSA:
83.47
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TINIDAZOLE
(2004)
Small molecule
DNA inhibitor
ORAL
Approved
Amebiasis; Bacterial Infections; Trichomonas Infections; Vaginal Diseases; Vaginosis, Bacterial
TINIDAZOLE
×
Maximum Phase:
4
First Approval:
2004
UNII:
033KF7V46H
Molecule Type:
Small molecule
Molecular Formula:
C8H13N3O4S
Molecular Weight:
247.28
AlogP:
0.53
PSA:
95.1
HBD:
0.0
HBA:
#RotB:
5.0
Source:
SYNTHETIC CONJUGATED ESTROGENS, B
(2004)
Small molecule
Estrogen receptor agonist
Unknown
Approved
Unknown
SYNTHETIC CONJUGATED ESTROGENS, B
×
Maximum Phase:
4
First Approval:
2004
UNII:
8L6LAK9BTR
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DULOXETINE HYDROCHLORIDE
(2004)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Anxiety Disorders; Chronic Pain; Depressive Disorder, Major; Fibromyalgia; Musculoskeletal Pain; Neuralgia
DULOXETINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2004
UNII:
9044SC542W
Molecule Type:
Small molecule
Molecular Formula:
C18H20ClNOS
Molecular Weight:
333.88
AlogP:
4.63
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ESZOPICLONE
(2004)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
ORAL
Approved
Sleep Initiation and Maintenance Disorders
ESZOPICLONE
×
Maximum Phase:
4
First Approval:
2004
UNII:
UZX80K71OE
Molecule Type:
Small molecule
Molecular Formula:
C17H17ClN6O3
Molecular Weight:
388.82
AlogP:
1.57
PSA:
91.76
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ERLOTINIB
(2004)
Small molecule
Unknown
Unknown
Approved
Neoplasms
ERLOTINIB
×
Maximum Phase:
4
First Approval:
2004
UNII:
J4T82NDH7E
Molecule Type:
Small molecule
Molecular Formula:
C22H23N3O4
Molecular Weight:
393.44
AlogP:
3.41
PSA:
74.73
HBD:
1.0
HBA:
#RotB:
10.0
Source:
ILOPROST
(2004)
Small molecule
Prostanoid IP receptor agonist
INHALATION
Approved
Hypertension, Pulmonary; Pulmonary Arterial Hypertension; Thrombosis
ILOPROST
×
Maximum Phase:
4
First Approval:
2004
UNII:
JED5K35YGL
Molecule Type:
Small molecule
Molecular Formula:
C22H32O4
Molecular Weight:
360.49
AlogP:
3.54
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
8.0
Source:
PENTETIC ACID
(2004)
Small molecule
Unknown
Unknown
Approved
Unknown
PENTETIC ACID
×
Maximum Phase:
4
First Approval:
2004
UNII:
7A314HQM0I
Molecule Type:
Small molecule
Molecular Formula:
C14H23N3O10
Molecular Weight:
393.35
AlogP:
-2.68
PSA:
196.22
HBD:
5.0
HBA:
#RotB:
16.0
Source:
CINACALCET HYDROCHLORIDE
(2004)
Small molecule
Calcium sensing receptor positive allosteric modulator
ORAL
Approved
Carcinoma; Hyperparathyroidism, Secondary; Parathyroid Neoplasms; Renal Insufficiency, Chronic
CINACALCET HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2004
UNII:
1K860WSG25
Molecule Type:
Small molecule
Molecular Formula:
C22H23ClF3N
Molecular Weight:
393.88
AlogP:
6.14
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AZACITIDINE
(2004)
Small molecule
DNA (cytosine-5)-methyltransferase 1 inhibitor
INTRAVENOUS; SUBCUTANEOUS
Approved
Anemia; Anemia, Refractory, with Excess of Blasts; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Neoplasms; Thrombocytopenia
AZACITIDINE
×
Maximum Phase:
4
First Approval:
2004
UNII:
M801H13NRU
Molecule Type:
Small molecule
Molecular Formula:
C8H12N4O5
Molecular Weight:
244.21
AlogP:
-3.17
PSA:
143.72
HBD:
4.0
HBA:
#RotB:
2.0
Source:
SOLIFENACIN SUCCINATE
(2004)
Small molecule
Muscarinic acetylcholine receptor M2 antagonist
Unknown
Approved
Urinary Bladder, Overactive; Urinary Incontinence, Urge
SOLIFENACIN SUCCINATE
×
Maximum Phase:
4
First Approval:
2004
UNII:
KKA5DLD701
Molecule Type:
Small molecule
Molecular Formula:
C27H32N2O6
Molecular Weight:
480.56
AlogP:
3.86
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
2.0
Source:
TIOTROPIUM BROMIDE
(2004)
Small molecule
Muscarinic acetylcholine receptor M3 antagonist
INHALATION
Approved
Asthma; Bronchial Spasm; Bronchitis, Chronic; Emphysema; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive
TIOTROPIUM BROMIDE
×
Maximum Phase:
4
First Approval:
2004
UNII:
XX112XZP0J
Molecule Type:
Small molecule
Molecular Formula:
C19H24BrNO5S2
Molecular Weight:
490.44
AlogP:
2.35
PSA:
59.06
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PENTETATE CALCIUM TRISODIUM
(2004)
Small molecule
Radioactive metals chelating agent
INHALATION; INTRAVENOUS
Approved
Pulmonary Embolism
PENTETATE CALCIUM TRISODIUM
×
Maximum Phase:
4
First Approval:
2004
UNII:
G79YN26H5B
Molecule Type:
Small molecule
Molecular Formula:
C14H18CaN3Na3O10
Molecular Weight:
497.36
AlogP:
-2.68
PSA:
196.22
HBD:
5.0
HBA:
#RotB:
16.0
Source:
SORAFENIB TOSYLATE
(2005)
Small molecule
Platelet-derived growth factor receptor beta inhibitor
ORAL
Approved
Carcinoma, Renal Cell; Thyroid Neoplasms
SORAFENIB TOSYLATE
×
Maximum Phase:
4
First Approval:
2005
UNII:
5T62Q3B36J
Molecule Type:
Small molecule
Molecular Formula:
C28H24ClF3N4O6S
Molecular Weight:
637.04
AlogP:
5.55
PSA:
92.35
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TIGECYCLINE
(2005)
Small molecule
Bacterial 70S ribosome inhibitor
INTRAVENOUS
Approved
Bacterial Infections; Infections; Intraabdominal Infections
TIGECYCLINE
×
Maximum Phase:
4
First Approval:
2005
UNII:
70JE2N95KR
Molecule Type:
Small molecule
Molecular Formula:
C29H39N5O8
Molecular Weight:
585.66
AlogP:
0.51
PSA:
205.76
HBD:
7.0
HBA:
#RotB:
6.0
Source:
QUININE
(2005)
Small molecule
Unknown
Unknown
Approved
Malaria
QUININE
×
Maximum Phase:
4
First Approval:
2005
UNII:
A7V27PHC7A
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2O2
Molecular Weight:
324.42
AlogP:
3.17
PSA:
45.59
HBD:
1.0
HBA:
#RotB:
4.0
Source:
QUININE SULFATE
(2005)
Small molecule
Ferriprotoporphyrin IX inhibitor
ORAL
Approved
Malaria, Falciparum; Muscle Cramp
QUININE SULFATE
×
Maximum Phase:
4
First Approval:
2005
UNII:
KF7Z0E0Q2B
Molecule Type:
Small molecule
Molecular Formula:
C40H54N4O10S
Molecular Weight:
782.96
AlogP:
3.17
PSA:
45.59
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NELARABINE
(2005)
Small molecule
DNA inhibitor
INTRAVENOUS
Approved
Leukemia-Lymphoma, Adult T-Cell; Neoplasms
NELARABINE
×
Maximum Phase:
4
First Approval:
2005
UNII:
60158CV180
Molecule Type:
Small molecule
Molecular Formula:
C11H15N5O5
Molecular Weight:
297.27
AlogP:
-1.97
PSA:
148.77
HBD:
4.0
HBA:
#RotB:
3.0
Source:
1
2
…
54
55
56
57
58
59
60
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA